<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>FCS Weekly / FCS 一周 (English)</title>
<link>https://weekly.livingwithfcs.org/</link>
<description>A weekly digest of FCS and severe high-triglyceride research, treatments, regulation and devices.</description>
<item>
<title>FCS Weekly — Issue 2 · November 20, 2026</title>
<link>https://weekly.livingwithfcs.org/issues/2026-11-20-issue-02-en.html</link>
<guid>https://weekly.livingwithfcs.org/issues/2026-11-20-issue-02-en.html</guid>
<pubDate>2026-11-20T12:00:00-07:00</pubDate>
<description>EU approves Tryngolza for severe hypertriglyceridemia; Plozasiran enters China&#x27;s national reimbursement list; A head-to-head without a trial</description>
</item>
<item>
<title>FCS Weekly — Issue 1 · November 13, 2026</title>
<link>https://weekly.livingwithfcs.org/issues/2026-11-13-issue-01-en.html</link>
<guid>https://weekly.livingwithfcs.org/issues/2026-11-13-issue-01-en.html</guid>
<pubDate>2026-11-13T12:00:00-07:00</pubDate>
<description>Plozasiran cuts pancreatitis risk by 78% in severe hypertriglyceridemia; Three years on; A first for gene editing</description>
</item>
</channel>
</rss>
